AxioSonic Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $250K
Latest Deal Amount
  • Investors
  • 2

AxioSonic General Information


Developer of non-invasive treatment intended to treat chronic sinusitis. The company uses a proprietary multimodal frequency system to treat facial pain and reduce symptoms of chronic sinusitis without the use of any medication, enabling healthcare providers to improve pain scores, sinus symptom scores and patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Outcome Management (Healthcare)
Primary Office
  • Effingham, IL 62401
  • United States

AxioSonic Timeline

Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AxioSonic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 11-Sep-2018 $250K 00000 Completed Startup
1. Accelerator/Incubator 12-Jun-2018 Completed Startup
To view AxioSonic’s complete valuation and funding history, request access »

AxioSonic Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EvoNexus Accelerator/Incubator Minority 000 0000 000000 0
MedTech Innovator Accelerator/Incubator 000 0000 000000 0
To view AxioSonic’s complete investors history, request access »